AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

LONDON and PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 152,802 ACUT shares in the open market. This brings his total holding to 4,872,759 shares.

About AccuStem

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes and quality of life for all patients with cancer. We plan to drive innovation in healthcare by offering proprietary molecular testing that addresses unmet clinical needs from cancer screening through treatment and monitoring. By interrogating novel disease pathways, such as tumor “stemness”, we believe our tools will help care teams better understand the biology of each patient’s cancer, leading to more informed decision making. For more information, please visit www.accustem.com.

Investor and Media Contact:
Wendy Blosser
Email: [email protected]

Source: AccuStem Sciences, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• HAIRCUTS FOR HEROES EVENT PROVIDES FREE HAIRCUTS FOR VETERANS, FIRST RESPONDERS, AND ACTIVE-DUTY SERVICE MEMBERS
• New York Academy of Medicine’s 2025 Impact Report
• CIC Services Launches PortfolioVantage Tenant Legal Liability Program for Property Owners